Bone microstructural defects and osteopenia in hemizygous βIVSII-654 knockin thalassemic mice: Sex-dependent changes in bone density and osteoclast function

American Journal of Physiology - Endocrinology and Metabolism

Volumn 309, Issue 11, 2015, Pages E936-E948

  Thongchote, Kanogwun ^a   Svasti, Saovaros ^a   Teerapornpuntakit, Jarinthorn ^a   Suntornsaratoon, Panan ^a   Krishnamra, Nateetip ^a   Charoenphandhu, Narattaphol ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Bone histomorphometry; Bone mineral density; Osteoporosis; thalassemia

Indexed keywords

HEMOGLOBIN BETA CHAIN; CALCEIN; FLUORESCEIN DERIVATIVE; FLUORESCENT DYE;

ADULT; AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA THALASSEMIA; BONE DEFECT; BONE DENSITY; BONE LENGTH; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GENE MUTATION; GROWTH RETARDATION; HEMIZYGOSITY; INTRON; MALE; MORPHOMETRICS; MOUSE; MOUSE STRAIN; NONHUMAN; OSSIFICATION; OSTEOCLAST; OSTEOPENIA; PRIORITY JOURNAL; RNA SPLICING; SEX DIFFERENCE; TRABECULAR BONE; AGING; ANIMAL; BONE; C57BL MOUSE; CHEMISTRY; CROSS BREEDING; GENE TARGETING; GROWTH PLATE; MECHANICS; METABOLISM; OSTEOPOROSIS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSICAL CHEMISTRY; SEXUAL DEVELOPMENT; SUBCUTANEOUS DRUG ADMINISTRATION; TRANSGENIC MOUSE;

AGING; ANIMALS; BETA-THALASSEMIA; BONE AND BONES; BONE DENSITY; CROSSES, GENETIC; FEMALE; FLUORESCEINS; FLUORESCENT DYES; GENE KNOCK-IN TECHNIQUES; GROWTH PLATE; INJECTIONS, SUBCUTANEOUS; MALE; MECHANICAL PHENOMENA; MICE, INBRED C57BL; MICE, TRANSGENIC; OSTEOCLASTS; OSTEOPOROSIS; PHYSICOCHEMICAL PHENOMENA; SEX CHARACTERISTICS;

EID: 84949310147     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00329.2015     Document Type: Article

References (40)

1. Aloia JF, Ostuni JA, Yeh JK, Zaino EC. Combined vitamin D parathyroid defect in thalassemia major. Arch Intern Med 142: 831–832, 1982.
2. Armbrecht HJ, Zenser TV, Bruns ME, Davis BB. Effect of age on intestinal calcium absorption and adaptation to dietary calcium. Am J Physiol Endocrinol Metab Gastrointest Physiol 236: E769–E774, 1979.
3. Bai XC, Lu D, Liu AL, Zhang ZM, Li XM, Zou ZP, Zeng WS, Cheng BL, Luo SQ. Reactive oxygen species stimulates receptor activator of NF-κB ligand expression in osteoblast. J Biol Chem 280: 17497–17506, 2005.
4. Brown AJ, Krits I, Armbrecht HJ. Effect of age, vitamin D, and calcium on the regulation of rat intestinal epithelial calcium channels. Arch Biochem Biophys 437: 51–58, 2005.
5. Charoenphandhu N, Kraidith K, Teerapornpuntakit J, Thongchote K, Khuituan P, Svasti S, Krishnamra N. 1,25-Dihydroxyvitamin D3-induced intestinal calcium transport is impaired in β-globin knockout thalassemic mice. Cell Biochem Funct 31: 685–691, 2013.
6. Cheng TC, Orkin SH, Antonarakis SE, Potter MJ, Sexton JP, Markham AF, Giardina PJ, Li A, Kazazian HH Jr. β-Thalassemia in Chinese: use of in vivo RNA analysis and oligonucleotide hybridization in systematic characterization of molecular defects. Proc Natl Acad Sci USA 81: 2821–2825, 1984.
7. De Sanctis V. Growth and puberty and its management in thalassaemia. Horm Res 58, Suppl 1: 72–79, 2002.
8. De Sanctis V, Vullo C, Katz M, Wonke B, Hoffbrand AV, Bagni B. Hypothalamic-pituitary-gonadal axis in thalassemic patients with secondary amenorrhea. Obstet Gynecol 72: 643–647, 1988.
9. Dempster DW, Compston JE, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR, Parfitt AM. Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 28: 2–17, 2013.
10. Dundar U, Kupesiz A, Ozdem S, Gilgil E, Tuncer T, Yesilipek A, Gultekin M. Bone metabolism and mineral density in patients with β-thalassemia major. Saudi Med J 28: 1425–1429, 2007.
11. Eriksen E, Axelrod D, Melsen F. Bone Histomorphometry. New York: Raven, 1994, p. 33–50.
12. Gardenghi S, Marongiu MF, Ramos P, Guy E, Breda L, Chadburn A, Liu Y, Amariglio N, Rechavi G, Rachmilewitz EA, Breuer W, Cabantchik ZI, Wrighting DM, Andrews NC, de Sousa M, Giardina PJ, Grady RW, Rivella S. Ineffective erythropoiesis in β-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin. Blood 109: 5027–5035, 2007.
13. Griffiths WJ, Sly WS, Cox TM. Intestinal iron uptake determined by divalent metal transporter is enhanced in HFE-deficient mice with hemochromatosis. Gastroenterology 120: 1420–1429, 2001.
14. Haidar R, Musallam KM, Taher AT. Bone disease and skeletal complications in patients with β thalassemia major. Bone 48: 425–432, 2011.
15. Kameda T, Mano H, Yuasa T, Mori Y, Miyazawa K, Shiokawa M, Nakamaru Y, Hiroi E, Hiura K, Kameda A, Yang NN, Hakeda Y, Kumegawa M. Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts. J Exp Med 186: 489–495, 1997.
16. Kazazian HH Jr, Boehm CD. Molecular basis and prenatal diagnosis of β-thalassemia. Blood 72: 1107–1116, 1988.
17. Kwan Tat S, Padrines M, Theoleyre S, Heymann D, Fortun Y. IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev 15: 49–60, 2004.
18. Lacey DL, Grosso LE, Moser SA, Erdmann J, Tan HL, Pacifici R, Villareal DT. IL-1-induced murine osteoblast IL-6 production is mediated by the type 1 IL-1 receptor and is increased by 1,25 dihydroxyvitamin D3. J Clin Invest 91: 1731–1742, 1993.
19. Lewis J, Yang B, Kim R, Sierakowska H, Kole R, Smithies O, Maeda N. A common human β globin splicing mutation modeled in mice. Blood 91: 2152–2156, 1998.
20. Li R, Zhao F, Diao H, Xiao S, Ye X. Postweaning dietary genistein exposure advances puberty without significantly affecting early pregnancy in C57BL/6J female mice. Reprod Toxicol 44: 85–92, 2014.
21. Liakakos D, Vlachos P, Anoussakis C, Constantinides C, Tsakalosos I. Calcium metabolism in children suffering from homozygous β-thalassaemia after oral administration of 47Ca. Nuklearmedizin 15: 77–79, 1976.
22. Mahachoklertwattana P, Yimsumruay T, Poomthavorn P, Chuansumrit A, Khlairit P. Acute effects of blood transfusion on growth hormone and insulin-like growth factor-1 levels in children with thalassemia. Horm Res Paediatr 75: 240–245, 2011.
23. Salsaa B, Zoumbos NC. A distinct pattern of cytokine production from blood mononuclear cells in multitransfused patients with β-thalassaemia. Clin Exp Immunol 107: 589–592, 1997.
24. Sanyear C, Butthep P, Nithipongvanich R, Sirankapracha P, Winichagoon P, Fucharoen S, Svasti S. Cardiomyocyte ultrastructural damage in β-thalassaemic mice. Int J Exp Pathol 94: 336–342, 2013.
25. Song Y, Fleet JC. 1,25 Dihydroxycholecalciferol-mediated calcium absorption and gene expression are higher in female than in male mice. J Nutr 134: 1857–1861, 2004.
26. Srinoun K, Svasti S, Chumworathayee W, Vadolas J, Vattanaviboon P, Fucharoen S, Winichagoon P. Imbalanced globin chain synthesis determines erythroid cell pathology in thalassemic mice. Haematologica 94: 1211–1219, 2009.
27. Suntornsaratoon P, Kraidith K, Teerapornpuntakit J, Dorkkam N, Wongdee K, Krishnamra N, Charoenphandhu N. Pre-suckling calcium supplementation effectively prevents lactation-induced osteopenia in rats. Am J Physiol Endocrinol Metab 306: E177–E188, 2014.
28. Suntornsaratoon P, Wongdee K, Goswami S, Krishnamra N, Charoenphandhu N. Bone modeling in bromocriptine-treated pregnant and lactating rats: possible osteoregulatory role of prolactin in lactation. Am J Physiol Endocrinol Metab 299: E426–E436, 2010.
29. Tenopoulou M, Doulias PT, Barbouti A, Brunk U, Galaris D. Role of compartmentalized redox-active iron in hydrogen peroxide-induced DNA damage and apoptosis. Biochem J 387: 703–710, 2005.
30. IVSII-654 knockin thalassemic mice. Histochem Cell Biol 136: 47–56, 2011.
31. Thongchote K, Svasti S, Teerapornpuntakit J, Krishnamra N, Charoenphandhu N. Running exercise alleviates trabecular bone loss and osteopenia in hemizygous β-globin knockout thalassemic mice. Am J Physiol Endocrinol Metab 306: E1406–E1417, 2014.
32. Tsitoura S, Amarilio N, Lapatsanis P, Pantelakis S, Doxiadis S. Serum 25-hydroxyvitamin D levels in thalassaemia. Arch Dis Child 53: 347–348, 1978.
33. Vanoaica L, Darshan D, Richman L, Schumann K, Kuhn LC. Intestinal ferritin H is required for an accurate control of iron absorption. Cell Metab 12: 273–282, 2010.
34. Vichinsky EP. The morbidity of bone disease in thalassemia. Ann NY Acad Sci 850: 344–348, 1998.
35. Villemure I, Stokes IA. Growth plate mechanics and mechanobiology. A survey of present understanding. J Biomech 42: 1793–1803, 2009.
36. o-thalassemia/HbE and their clinical significance. J Interferon Cytokine Res 19: 105–111, 1999.
37. Wang Y, Menendez A, Fong C, ElAlieh HZ, Chang W, Bikle DD. Ephrin B2/EphB4 mediates the actions of IGF-I signaling in regulating endochondral bone formation. J Bone Miner Res 29: 1900–1913, 2014.
38. Wronski TJ, Cintrón M, Doherty AL, Dann LM. Estrogen treatment prevents osteopenia and depresses bone turnover in ovariectomized rats. Endocrinology 123: 681–686, 1988.
39. Younoszai MK, Ghishan FK. In vivo intestinal calcium transport in infant rats: normal and growth retarded. J Nutr 109: 573–579, 1979.
40. Zhao B, Grimes SN, Li S, Hu X, Ivashkiv LB. TNF-induced osteoclastogenesis and inflammatory bone resorption are inhibited by transcription factor RBP-J. J Exp Med 209: 319–334, 2012.